Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma
Glaucoma is a complex neurodegenerative disease characterized by progressive visual dysfunction leading to vision loss. Retinal ganglion cells are the primary affected neuronal population, with a critical insult damaging their axons in the optic nerve head. This insult is typically secondary to harm...
Main Authors: | Simon W. M. John, Pete A. Williams, Jeffrey M. Harder, Nicole E. Foxworth, Brynn H. Cardozo, Kelly E. Cochran |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnins.2017.00232/full |
Similar Items
-
Nicotinamide treatment robustly protects from inherited mouse glaucoma
by: Pete A. Williams, et al.
Published: (2018-01-01) -
Sarm1 Deletion, but Not WldS, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
by: Jonathan Gilley, et al.
Published: (2017-10-01) -
NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion
by: Yo Sasaki, et al.
Published: (2016-10-01) -
NAD+-dependent mechanism of pathological axon degeneration
by: Ying Cao, et al.
Published: (2022-04-01) -
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve
by: James R. Tribble, et al.
Published: (2023-01-01)